PPBT
Purple Biotech
PPBT
PPBT
13 hedge funds and large institutions have $1.77M invested in Purple Biotech in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
57% less capital invested
Capital invested by funds: $4.09M → $1.77M (-$2.32M)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Holders
13
Holding in Top 10
–
Calls
$499K
Puts
$364K
Top Buyers
| 1 | +$198K | |
| 2 | +$105K | |
| 3 | +$71K | |
| 4 |
IA
IFP Advisors
Tampa,
Florida
|
+$1K |
Top Sellers
| 1 | -$2.58M | |
| 2 | -$61.6K | |
| 3 | -$38.9K | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$31.1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$4.24K |